ABN AMRO and ODDO BHF to join forces
ABN AMRO and ODDO BHF to join forces
ABN AMRO and Franco-German financial services group ODDO BHF are entering into a strategic partnership to combine their equity brokerage services in Benelux. Both parties have a leading position in their respective markets and have the ambition to extend their partnership to the German market.
A new joint venture named ABN AMRO-ODDO BHF will be established (*). Both parties will have an equal share in the joint venture. ABN AMRO will bring in its Benelux equity research, institutional sales, and sales trading activities. ODDO BHF will contribute its state-of-the-art platform and execution capabilities. The joint venture will have a Benelux focus and will be located at ABN AMRO’s headquarters in Amsterdam. ABN AMRO and ODDO BHF have the ambition to extend their partnership to the German market.
The partnership will enhance the equity capital markets, corporate broking and equity brokerage services to both corporate and institutional clients, creating a broader range of high-quality equity research of over 500 stocks and an extended distribution network of more than 600 institutional clients in Europe and the United States.
Opportunities for growth in Northwest Europe
Rutger van Nouhuijs, member of the ABN AMRO Executive Committee: “I am proud to announce this partnership. We have a leading equity franchise in Benelux. Partnering with a professional and complementary leading pan-European broker like ODDO BHF will further strengthen our local position and will enhance the equity services we provide to our clients. Additionally, this partnership provides opportunities to grow further into Northwest Europe, underlining our regional ambitions and reconfirming our strong commitment to the bank’s equity and equity capital markets franchise.”
Broader range of services and expertise
Christophe Tadié, Managing Partner of ODDO BHF and Head of Corporates & Markets: “We are very happy to be partnering with ABN AMRO. This new partnership brings together complementary teams, expertise and markets in order to build a consolidating brokerage platform in Europe by uniting the strengths of two leaders in their respective markets. After the partnership with Natixis, this alliance is part of our pan-European strategy aimed at building a financial leader in the eurozone. The brokerage activity is an important part of ODDO BHF’s history and DNA, and we are seeking to offer our clients a broader range of services and expertise.”
*The launch of the joint venture is subject to the approval of the supervisory and regulatory authorities.
ABN AMRO Press Office
+31 (6) 1276 3059
About ODDO BHF
ODDO BHF is an independent Franco-German financial services group, with a history stretching back over 170 years. It was created from the alliance of a French family-owned business built up by five generations of stockbrokers and a German bank specializing in SMEs. The group has 2,300 employees (1,200 in Germany and 1,100 in France and Tunisia), and over € 110 billion in client assets under management. Based on its significant investment in market expertise, ODDO BHF operates in three main businesses: private banking, asset management and corporate and investment banking. The Group has a unique ownership structure as 65% of its capital is held by the Oddo family and 25% by employees. This partnership ethos guarantees the long-term commitment of its teams. In 2019, ODDO BHF generated net banking income of € 585 million and at 31 December 2019 the group had over € 890 million in shareholders' equity.
About ABN AMRO
ABN AMRO is a Dutch bank for retail, corporate and private banking clients, offering a full range of financial products and solutions. Our focus is on Northwest Europe. Our ambition is to be the best Dutch bank. Our purpose Banking for better, for generations to come guides us in delivering on our strategy, which is based on three pillars: support our clients’ transition to sustainability, reinvent the customer experience, and build a future-proof bank. Headquartered in Amsterdam, we serve around six million clients and employ just under 18,000 people. Please visit us at www.abnamro.com.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Leasinvest Real Estate SCA: Important lease in the building Mercator in Luxembourg30.9.2020 17:40:00 CEST | Press release
New lease for a floor in the building Mercator Leasinvest Real Estate has just concluded a new lease for 1,560 m² with CHL – ‘Centre Hospitalier de Luxembourg’, in the building Mercator located Route d'Arlon 110-112 in the Grand Duchy of Luxembourg. This new lease concretises the in-principle agreement already announced in the half-year financial report published on 19 August 2020. The rent price amounts to € 22/m²/month and the contract starts tomorrow, 1 October 2020. The building Mercator has a total surface area of 8,641 m² of offices, spread across 5 floors and comprises 104 parking spaces, and benefits from an exceptional location in the capital of the Grand Duchy along the Route d’Arlon, one of the main axes to the City of Luxembourg. Moreover, the building Mercator is located nearby Luxembourg’s main hospital, around which an important number of (para)medical businesses are located. This transaction was realised with the intervention of Cushman & Wakefield. Michel Van Geyte, CE
Ress Life Investments A/S: Ress Life Investments A/S publishes Net Asset Value (NAV)30.9.2020 17:05:00 CEST | Press release
Ress Life Investments Holbergsgade 14, 2 tv DK-1057 Copenhagen K Denmark CVR nr. 33593163 www.resslifeinvestments.com To: Nasdaq Copenhagen Date: 30 September 2020 Corporate Announcement 36/2020 Ress Life Investments A/S publishes Net Asset Value (NAV). Ress Life Investments A/S publishes the Net Asset Value (NAV) per share and performance data as of 15 September 2020. NAV per share in USD: 2064.01 NAV per share in EUR: 1735.63 The performance during the first half of September was -0.49% in USD. The year-to-date net performance is 5.37% in USD. Assets under management (AUM) was 215.0 million US dollars. Questions related to this announcement can be made to the company's AIF-manager, Resscapital AB. Contact person: Gustaf Hagerud firstname.lastname@example.org Tel + 46 8 545 282 27 Note: The terms for subscription of shares, minimum subscription amount and redemption of shares are provided in the Articles of Association, Information Brochure and in the Key Investment Information Docume
Vaisala’s financial information and Annual General Meeting in 202130.9.2020 17:00:00 CEST | Press release
Vaisala Corporation Stock exchange release September 30, 2020 at 6:00 p.m. EEST Vaisala’s financial information and Annual General Meeting in 2021 Vaisala Corporation will publish its Financial Statement Release, Half Year Financial Report and two Interim Reports during 2021 as follows: - February 19, 2021: Financial Statement Release 2020 - April 29, 2021: Interim Report January–March 2021 - July 23, 2021: Half Year Financial Report 2021 - October 28, 2021: Interim Report January–September 2021 The Annual Report 2020 will be published at vaisala.com by the end of week 9. Vaisala Corporation’s Annual General Meeting is scheduled for Tuesday, March 30, 2021. The Board of Directors of the company will convene the meeting. More information Paula Liimatta, Business Controller and Head of Investor Relations Tel. +358 40 580 3521 Distribution Nasdaq Helsinki Key media vaisala.com Vaisala is a global leader in environmental and industrial measurement. Building on over 80 years of experience,
SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING30.9.2020 16:20:00 CEST | Press release
SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING 2020-10-02 Transaction type:SEK CreditTender date:2020-10-02Time for submission of bids:10.30-11.00 (CEST)Payment date:2020-10-06Final repayment date2024-10-07Offered volume:50 billion SEKMinimum bid amount:10 million SEKMaximum bid amount:12.5 billion SEKMaximum number of bids from each participant: 1Interest rate:0.00 %Additional interest rate:0.10 per cent ALL APPROVED COUNTERPARTIES ARE INVITED TO SUBMIT VOLUME BIDS TO THE RIKSBANK (46-8-6966970) BY 11.00 ON OCTOBER 2 2020, AT THE LATEST. CONFIRMATION ON E-MAIL: email@example.com Result of the auction will be published at 11.30 (CEST) on Tender date. Complete terms and conditions can be retrieved at http://www.riksbank.se
Auction details government bonds30.9.2020 16:20:00 CEST | Press release
Auction date October 7, 2020 Maturity date Loan ISIN code Coupon Issue volume, SEK million 2028-05-12 1060 SE0009496367 0.75% 4,000 2032-06-01 1056 SE0004517290 2,25% 1,000 Settlement date October 9, 2020 Bids have to be entered by 11.00 on October 7, 2020 Bid only through dealers approved by the Swedish National Debt Office For more information, please contact: The funding desk + 46 8 613 4780 FO@riksgalden.se
Change in numbers of shares and votes in Saniona AB (publ)30.9.2020 16:00:00 CEST | Press release
PRESS RELEASE September 30, 2020 During September, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to the exercising of warrants of series TO 2. As of September 30, 2020, the registered number of shares and votes in Saniona amounts to 62,372,831. For more information, please contact Trista Morrison, Chief Communications Officer. Mobile + 1 (858) 229 1738. Email: firstname.lastname@example.org This information is such information as Saniona AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 4 p.m. CET on September 30, 2020. About Saniona Saniona is a rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system. The company has four programs in clinical development. Saniona intends to develop and commercialize treatments f